Positive Allosteric Modulators of Dopamine 1 Receptor and Methods of Use Thereof
France
19716018.7
Filed on 2020-09-15
19716018.7
Filed on 2020-09-15
Genetic control of MRI signal
Patent Cooperation Treaty
PCT/US2024/011377
Filed on 2024-01-12
PCT/US2024/011377
Filed on 2024-01-12
D3 Dopamine Receptor-Selective Negative Allosteric Modulators.
European Patent
22761746.1
Filed on 2024-01-29
22761746.1
Filed on 2024-01-29
D3 Dopamine Receptor-Selective Negative Allosteric Modulators.
US Application 18/294,663
Filed on 2024-02-02
Filed on 2024-02-02
ANGUBINDIN-1 TREATMENT AGAINST MALIGNANT GLIOMA
Patent Cooperation Treaty
PCT/US2023/079547
Filed on 2023-11-13
PCT/US2023/079547
Filed on 2023-11-13
RECOMBINANT POLYPEPTIDES COMPRISING SINGLE-DOMAIN ANTIBODIES TARGETING HERV-K SUBTYPE HML-2
Patent Cooperation Treaty
PCT/US2023/066224
Filed on 2023-04-26
PCT/US2023/066224
Filed on 2023-04-26
SELECTIVE D3 DOPAMINE RECEPTOR AGONISTS AND METHODS OF THEIR USE
US Patent 12,145,922
Filed on 2023-02-17
Filed on 2023-02-17
Therapeutics for the Treatment of Neurodegenerative Disorders
Patent Cooperation Treaty
PCT/EP2021/084908
Filed on 2021-12-09
PCT/EP2021/084908
Filed on 2021-12-09
Therapeutics for the Treatment of Neurodegenerative Disorders
United Kingdom
2117758.9
Filed on 2021-12-09
2117758.9
Filed on 2021-12-09